Search results for N-terminal

Anti-eIF4A1 antibody [EPR14505(B)] - N-terminal, Abcam, AB180506

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CD10 antibody [SP179] (N-terminal), Abcam, AB306503

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Procollagen III N-Terminal Propeptide (PIIINP) Antibody, Abbexa, abx405912

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product. Procollagen III N-Terminal Propeptide (PIIINP) Antibody is a Rabbit polyclonal against Procollagen III N-Terminal Propeptide (PIIINP).

Anti-Desmoglein 3/PVA antibody - N-terminal, Abcam, AB228726

Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal, Abcam, AB215191

Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IP and WB. Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) was first used in a scientific publication in 2017 and has been cited over 153 times in peer reviewed journals. It's performance in Western blot in mouse samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) has been confirmed by Western Blot testing in DFNA5/GSDME knockout SGC-7901 cells. Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) has 4 independent reviews from customers. Anti-DFNA5/GSDME antibody [EPR19859] - N-terminal (ab215191) specifically detects DFNA5/GSDME (UniProt ID: O60443; Molecular weight: 55kDa) and is sold in 100 µL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EPR19859 - ab223877 . Antibody clone EPR19859 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 488, PE ( ab225519 , ab225520 ). Gasdermin E (GSDME) plays a significant role in immunology by modulating the immune response, particularly through its involvement in pyroptosis, a form of programmed cell death Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-DGAT1 antibody [EPR13430-4] - N-terminal, Abcam, AB181180

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-POC5 antibody [EPR14000-76] - N-terminal, Abcam, AB188330

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Procollagen III N-Terminal Propeptide (PIIINP) Antibody, Abbexa, abx170007

Procollagen III N-Terminal Propeptide (PIIINP) Antibody is a Rabbit Polyclonal against Procollagen III N-Terminal Propeptide (PIIINP).

Anti-PsbA (D1) (N terminal) GLOBAL ANTIBODY, Agrisera, AS11 1786

Peptide target used for antibody production comes from Helix 1 of PSII, lumenal exposed loop. Antibodies are going to recognize the target in a wide range of species. This product can be sold containing ProClin if requested.

N-Terminal Kinase-Like Protein (SCYL1) Antibody, Abbexa, abx321032

SCYL1 Antibody is a Rabbit Polyclonal against SCYL1.